Sphere Fluidics Ltd has raised $2 million from investors to accelerate growth and support the sales of its single cell analysis system which is used to recognise biological targets and improve antibody discovery.
The funds were provided by Greenwood Way Capital, Oxford Technology and Innovations EIS Fund and 24Haymarket.
Sphere Fluidics is located in Babraham, Cambridgeshire, UK and Monmouth Junction, New Jersey, US.
The company announced the funding on 29 January 2019.
Copyright 2019 Evernow Publishing Ltd